|
1
|
Rousseau A, Mokhtari K and Duyckaerts C:
The 2007 WHO classification of tumors of the central nervous
system-what has changed? Curr Opin Neurol. 21:720–727. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Genetic pathways
to primary and secondary glioblastoma. Am J Pathol. 170:1445–1453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shukla A, Miller JM, Cason C, Sayan M,
MacPherson MB, Beuschel SL, Hillegass J, Vacek PM, Pass HI and
Mossman BT: Extracellular signal-regulated kinase 5: A potential
therapeutic target for malignant mesotheliomas. Clin Cancer Res.
19:2071–2083. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen W, Zhang B, Guo W, Gao L, Shi L, Li
H, Lu S, Liu Y and Li X: miR-429 inhibits glioma invasion through
BMK1 suppression. J Neurooncol. 125:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song C, Wang L, Xu Q, Wang K, Xie D, Yu Z,
Jiang K, Liao L, Yates JR, Lee JD and Yang Q: Targeting BMK1
impairs the drug resistance to combined inhibition of BRAF and
MEK1/2 in melanoma. Sci Rep. 7:462442017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rovida E, Di Maira G, Tusa I, Cannito S,
Paternostro C, Navari N, Vivoli E, Deng X, Gray NS, Esparís-Ogando
A, et al: The mitogen-activated protein kinase ERK5 regulates the
development and growth of hepatocellular carcinoma. Gut.
64:1454–1465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao L, Sun Y, Hou Y, Peng Q, Wang L, Luo
H, Tang X, Zeng Z and Liu M: miRNA expression analysis of
cancer-associated fibroblasts and normal fibroblasts in breast
cancer. Int J Biochem Cell Biol. 44:2051–2059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krek A, Grun D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
16
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
17
|
Bandres E, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M and
García-Foncillas J: Identification by Real-time PCR of 13 mature
microRNAs differentially expressed in colorectal cancer and
non-tumoral tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Papaconstantinou IG, Manta A, Gazouli M,
Lyberopoulou A, Lykoudis PM, Polymeneas G and Voros D: Expression
of microRNAs in patients with pancreatic cancer and its prognostic
significance. Pancreas. 42:67–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
−145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun L, Zhang B, Liu Y, Shi L, Li H and Lu
S: miR125a-5p acting as a novel Gab2 suppressor inhibits invasion
of glioma. Mol Carcinog. 55:40–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ufkin ML, Peterson S, Yang X, Driscoll H,
Duarte C and Sathyanarayana P: miR-125a regulates cell cycle,
proliferation, and apoptosis by targeting the ErbB pathway in acute
myeloid leukemia. Leuk Res. 38:402–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang L, Lin C, Song L, Wu J, Chen B, Ying
Z, Fang L, Yan X, He M, Li J and Li M: MicroRNA-30e* promotes human
glioma cell invasiveness in an orthotopic xenotransplantation model
by disrupting the NF-κB/IκBα negative feedback loop. J Clin Invest.
122:33–47. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N,
Liang S, Lu S, Liu Y, Zhang J, et al: PTTG1 promotes migration and
invasion of human non-small cell lung cancer cells and is modulated
by miR-186. Carcinogenesis. 34:2145–2155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Tu Y, Wen J, Yao F, Wei W and Sun S:
Role for ezrin in breast cancer cell chemotaxis to CCL5. Oncol Rep.
24:965–971. 2010.PubMed/NCBI
|
|
27
|
Wang LH, Xiang J, Yan M, Zhang Y, Zhao Y,
Yue CF, Xu J, Zheng FM, Chen JN, Kang Z, et al: The mitotic kinase
Aurora-A induces mammary cell migration and breast cancer
metastasis by activating the Cofilin-F-actin pathway. Cancer Res.
70:9118–9128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hall EH, Gurel V, Dahlberg AE, McMichael J
and Brautigan DL: Inhibition of human breast cancer Matrigel
invasion by Streptolysin O activation of the EGF receptor ErbB1.
Cell Signal. 23:1972–1977. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan LP, Seinen E, Duns G, de Jong D, Sibon
OC, Poppema S, Kroesen BJ, Kok K and van den Berg A: A high
throughput experimental approach to identify miRNA targets in human
cells. Nucleic Acids Res. 37:e1372009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng GZ, Zhang W and Wang LH: Regulation
of cancer cell survival, migration, and invasion by Twist: AKT2
comes to interplay. Cancer Res. 68:957–960. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi L, Sun X, Zhang J, Zhao C, Li H, Liu
Z, Fang C, Wang X, Zhao C, Zhang X, et al: Gab2 expression in
glioma and its implications for tumor invasion. Acta Oncol.
52:1739–1750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Villa C, Miquel C, Mosses D, Bernier M and
Di Stefano AL: The 2016 World Health Organization classification of
tumours of the central nervous system. Presse Med. 47:e187–e200.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He Y, Li D, Cook SL, Yoon MS, Kapoor A,
Rao CV, Kenis PJ, Chen J and Wang F: Mammalian target of rapamycin
and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42
activity and the actin cytoskeleton. Mol Biol Cell. 24:3369–3380.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ghosh M, Song X, Mouneimne G, Sidani M,
Lawrence DS and Condeelis JS: Cofilin promotes actin polymerization
and defines the direction of cell motility. Science. 304:743–746.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Etienne-Manneville S and Hall A:
Integrin-mediated activation of Cdc42 controls cell polarity in
migrating astrocytes through PKCzeta. Cell. 106:489–498. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tran TT, Uhl M, Ma JY, Janssen L, Sriram
V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, et al: Inhibiting
TGF-beta signaling restores immune surveillance in the SMA-560
glioma model. Neuro Oncol. 9:259–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yim RL, Wong KY, Kwong YL, Loong F, Leung
CY, Chu R, Lam WW, Hui PK, Lai R and Chim CS: Methylation of
miR-155-3p in mantle cell lymphoma and other non-Hodgkin's
lymphomas. Oncotarget. 5:9770–9782. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Noritake J, Watanabe T, Sato K, Wang S and
Kaibuchi K: IQGAP1: A key regulator of adhesion and migration. J
Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang B, Gu F, She C, Guo H, Li W, Niu R,
Fu L, Zhang N and Ma Y: Reduction of Akt2 inhibits migration and
invasion of glioma cells. Int J Cancer. 125:585–595. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu TG, Wang L, Li W, Li JZ and Li J:
miR-143 inhibits oncogenic traits by degrading NUAK2 in
glioblastoma. Int J Mol Med. 37:1627–1635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wynter CV: The dialectics of cancer: A
theory of the initiation and development of cancer through errors
in RNAi. Med Hypotheses. 66:612–635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ren X, McHale CM, Skibola CF, Smith AH,
Smith MT and Zhang L: An emerging role for epigenetic dysregulation
in arsenic toxicity and carcinogenesis. Environ Health Perspect.
119:11–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
